Copyright Reports & Markets. All rights reserved.

Global Natural Killer Cell Therapies Market Research Report 2020

Request for Sample of this report
Buy now

1 Natural Killer Cell Therapies Market Overview

  • 1.1 Product Overview and Scope of Natural Killer Cell Therapies
  • 1.2 Natural Killer Cell Therapies Segment by Type
    • 1.2.1 Global Natural Killer Cell Therapies Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 NK Cell Therapies
    • 1.2.3 NK Cell Directed Antibodies
  • 1.3 Natural Killer Cell Therapies Segment by Application
    • 1.3.1 Natural Killer Cell Therapies Sales Comparison by Application: (2020-2026)
    • 1.3.2 Cancer
    • 1.3.3 Gastrointestinal Diseases
    • 1.3.4 Others
  • 1.4 Global Natural Killer Cell Therapies Market Size Estimates and Forecasts
    • 1.4.1 Global Natural Killer Cell Therapies Revenue 2015-2026
    • 1.4.2 Global Natural Killer Cell Therapies Sales 2015-2026
    • 1.4.3 Natural Killer Cell Therapies Market Size by Region: 2020 Versus 2026

2 Global Natural Killer Cell Therapies Market Competition by Manufacturers

  • 2.1 Global Natural Killer Cell Therapies Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Natural Killer Cell Therapies Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Natural Killer Cell Therapies Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Natural Killer Cell Therapies Manufacturing Sites, Area Served, Product Type
  • 2.5 Natural Killer Cell Therapies Market Competitive Situation and Trends
    • 2.5.1 Natural Killer Cell Therapies Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Natural Killer Cell Therapies Players (Opinion Leaders)

3 Natural Killer Cell Therapies Retrospective Market Scenario by Region

  • 3.1 Global Natural Killer Cell Therapies Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Natural Killer Cell Therapies Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Natural Killer Cell Therapies Market Facts & Figures by Country
    • 3.3.1 North America Natural Killer Cell Therapies Sales by Country
    • 3.3.2 North America Natural Killer Cell Therapies Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Natural Killer Cell Therapies Market Facts & Figures by Country
    • 3.4.1 Europe Natural Killer Cell Therapies Sales by Country
    • 3.4.2 Europe Natural Killer Cell Therapies Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Natural Killer Cell Therapies Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Natural Killer Cell Therapies Sales by Region
    • 3.5.2 Asia Pacific Natural Killer Cell Therapies Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Natural Killer Cell Therapies Market Facts & Figures by Country
    • 3.6.1 Latin America Natural Killer Cell Therapies Sales by Country
    • 3.6.2 Latin America Natural Killer Cell Therapies Sales by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Natural Killer Cell Therapies Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Natural Killer Cell Therapies Sales by Country
    • 3.7.2 Middle East and Africa Natural Killer Cell Therapies Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Natural Killer Cell Therapies Historic Market Analysis by Type

  • 4.1 Global Natural Killer Cell Therapies Sales Market Share by Type (2015-2020)
  • 4.2 Global Natural Killer Cell Therapies Revenue Market Share by Type (2015-2020)
  • 4.3 Global Natural Killer Cell Therapies Price Market Share by Type (2015-2020)
  • 4.4 Global Natural Killer Cell Therapies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Natural Killer Cell Therapies Historic Market Analysis by Application

  • 5.1 Global Natural Killer Cell Therapies Sales Market Share by Application (2015-2020)
  • 5.2 Global Natural Killer Cell Therapies Revenue Market Share by Application (2015-2020)
  • 5.3 Global Natural Killer Cell Therapies Price by Application (2015-2020)

6 Company Profiles and Key Figures in Natural Killer Cell Therapies Business

  • 6.1 Nektar Therapeutics
    • 6.1.1 Corporation Information
    • 6.1.2 Nektar Therapeutics Description, Business Overview
    • 6.1.3 Nektar Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 Nektar Therapeutics Products Offered
    • 6.1.5 Nektar Therapeutics Recent Development
  • 6.2 Innate
    • 6.2.1 Innate Corporation Information
    • 6.2.2 Innate Description, Business Overview
    • 6.2.3 Innate Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 Innate Products Offered
    • 6.2.5 Innate Recent Development
  • 6.3 Affimed
    • 6.3.1 Affimed Corporation Information
    • 6.3.2 Affimed Description, Business Overview
    • 6.3.3 Affimed Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Affimed Products Offered
    • 6.3.5 Affimed Recent Development
  • 6.4 Chipscreen Biosciences
    • 6.4.1 Chipscreen Biosciences Corporation Information
    • 6.4.2 Chipscreen Biosciences Description, Business Overview
    • 6.4.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Chipscreen Biosciences Products Offered
    • 6.4.5 Chipscreen Biosciences Recent Development
  • 6.5 Fate Therapeutics
    • 6.5.1 Fate Therapeutics Corporation Information
    • 6.5.2 Fate Therapeutics Description, Business Overview
    • 6.5.3 Fate Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Fate Therapeutics Products Offered
    • 6.5.5 Fate Therapeutics Recent Development
  • 6.6 Glycostem
    • 6.6.1 Glycostem Corporation Information
    • 6.6.2 Glycostem Description, Business Overview
    • 6.6.3 Glycostem Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 Glycostem Products Offered
    • 6.6.5 Glycostem Recent Development
  • 6.7 Dragonfly Therapeutics
    • 6.6.1 Dragonfly Therapeutics Corporation Information
    • 6.6.2 Dragonfly Therapeutics Description, Business Overview
    • 6.6.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Dragonfly Therapeutics Products Offered
    • 6.7.5 Dragonfly Therapeutics Recent Development
  • 6.8 Kiadis Pharma
    • 6.8.1 Kiadis Pharma Corporation Information
    • 6.8.2 Kiadis Pharma Description, Business Overview
    • 6.8.3 Kiadis Pharma Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 Kiadis Pharma Products Offered
    • 6.8.5 Kiadis Pharma Recent Development
  • 6.9 NantWorks
    • 6.9.1 NantWorks Corporation Information
    • 6.9.2 NantWorks Description, Business Overview
    • 6.9.3 NantWorks Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.9.4 NantWorks Products Offered
    • 6.9.5 NantWorks Recent Development
  • 6.10 Nkarta Therapeutics
    • 6.10.1 Nkarta Therapeutics Corporation Information
    • 6.10.2 Nkarta Therapeutics Description, Business Overview
    • 6.10.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.10.4 Nkarta Therapeutics Products Offered
    • 6.10.5 Nkarta Therapeutics Recent Development
  • 6.11 Fortress Biotech
    • 6.11.1 Fortress Biotech Corporation Information
    • 6.11.2 Fortress Biotech Natural Killer Cell Therapies Description, Business Overview
    • 6.11.3 Fortress Biotech Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
    • 6.11.4 Fortress Biotech Products Offered
    • 6.11.5 Fortress Biotech Recent Development

7 Natural Killer Cell Therapies Manufacturing Cost Analysis

  • 7.1 Natural Killer Cell Therapies Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Natural Killer Cell Therapies
  • 7.4 Natural Killer Cell Therapies Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Natural Killer Cell Therapies Distributors List
  • 8.3 Natural Killer Cell Therapies Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Natural Killer Cell Therapies Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Natural Killer Cell Therapies by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Natural Killer Cell Therapies by Type (2021-2026)
  • 10.2 Natural Killer Cell Therapies Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Natural Killer Cell Therapies by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Natural Killer Cell Therapies by Application (2021-2026)
  • 10.3 Natural Killer Cell Therapies Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Natural Killer Cell Therapies by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Natural Killer Cell Therapies by Region (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Natural Killer Cell Therapies market is segmented into
    NK Cell Therapies
    NK Cell Directed Antibodies

    Segment by Application
    Cancer
    Gastrointestinal Diseases
    Others

    Global Natural Killer Cell Therapies Market: Regional Analysis
    The Natural Killer Cell Therapies market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Natural Killer Cell Therapies market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global Natural Killer Cell Therapies Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Natural Killer Cell Therapies market include:
    Nektar Therapeutics
    Innate
    Affimed
    Chipscreen Biosciences
    Fate Therapeutics
    Glycostem
    Dragonfly Therapeutics
    Kiadis Pharma
    NantWorks
    Nkarta Therapeutics
    Fortress Biotech

    Buy now